Developmental Research Program

The Developmental Research Program in the Mayo Clinic Multiple Myeloma SPORE supports innovative, scientifically sound research projects in any area related to translational multiple myeloma research.

The Developmental Research Program supports developmental research that incorporates techniques and theoretical approaches that may not have been previously used in multiple myeloma research. The program aims to increase the number of scientists and clinical investigators committed to translational research in multiple myeloma.

The program supports two to three research projects a year for one year, with a second year of support possible based on exceptional progress toward the stated research goals. The program's long-term goal is to translate findings generated by developmental projects into a reduction in the incidence and mortality rate of multiple myeloma.

Program goals

The main goals of the Developmental Research Program are to:

  • Encourage innovative translational clinical and laboratory studies that are promising and have the potential to improve patient outcomes in multiple myeloma and mature into independently funded projects in the future
  • Foster extensive collaboration between basic science and clinical disciplines in translational research in myeloma within the SPORE
  • Encourage investigators to evaluate the potential of applying their research findings in other tumor types to translational research in multiple myeloma
  • Generate new hypotheses that can be tested and provide the foundation for future large-scale research projects or clinical trials in order to reduce the incidence and mortality of myeloma

The Multiple Myeloma SPORE calls for applications annually for the Developmental Research Program. The SPORE's Developmental Research Committee formally reviews submissions. Funds are awarded based on scientific merit, originality and relevance to the objectives of the SPORE.

Program leaders

Co-directors of the Developmental Research Program are: